LU83435A1 - Glucosaminoglycanes modifiees exercant une activite antilipemique et essentiellement exemptes d'activite anticoagulante - Google Patents

Glucosaminoglycanes modifiees exercant une activite antilipemique et essentiellement exemptes d'activite anticoagulante Download PDF

Info

Publication number
LU83435A1
LU83435A1 LU83435A LU83435A LU83435A1 LU 83435 A1 LU83435 A1 LU 83435A1 LU 83435 A LU83435 A LU 83435A LU 83435 A LU83435 A LU 83435A LU 83435 A1 LU83435 A1 LU 83435A1
Authority
LU
Luxembourg
Prior art keywords
heparin
activity
derivative
hydrolysis
minutes
Prior art date
Application number
LU83435A
Other languages
English (en)
French (fr)
Inventor
G Sportoletti
A Baglioni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of LU83435A1 publication Critical patent/LU83435A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/02—Resin hair settings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/04—Dandruff
LU83435A 1980-06-18 1981-06-17 Glucosaminoglycanes modifiees exercant une activite antilipemique et essentiellement exemptes d'activite anticoagulante LU83435A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22851/80A IT1140999B (it) 1980-06-18 1980-06-18 Glicosaminoglicani modificati dotati di attivita' antilipemica e privi di attivita' anticoagulante
IT2285180 1980-06-18

Publications (1)

Publication Number Publication Date
LU83435A1 true LU83435A1 (fr) 1981-10-29

Family

ID=11201157

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83435A LU83435A1 (fr) 1980-06-18 1981-06-17 Glucosaminoglycanes modifiees exercant une activite antilipemique et essentiellement exemptes d'activite anticoagulante

Country Status (21)

Country Link
US (1) US4459289A (ja)
JP (1) JPS5952164B2 (ja)
AR (1) AR227317A1 (ja)
AU (1) AU531118B2 (ja)
BE (1) BE889275A (ja)
DE (1) DE3123806A1 (ja)
DK (1) DK267681A (ja)
ES (1) ES503199A0 (ja)
FI (1) FI811832L (ja)
FR (1) FR2485019A1 (ja)
GB (1) GB2078768B (ja)
GR (1) GR75703B (ja)
IE (1) IE51273B1 (ja)
IT (1) IT1140999B (ja)
LU (1) LU83435A1 (ja)
NL (1) NL8102947A (ja)
NO (1) NO812055L (ja)
PH (1) PH17676A (ja)
PT (1) PT73214B (ja)
SE (1) SE8103677L (ja)
ZA (1) ZA814047B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1169888B (it) * 1983-10-25 1987-06-03 Italfarmaco Spa Glicosaminoglicani modificati dotati di attivita' antitrombotica
JPS61250374A (ja) * 1985-04-29 1986-11-07 Honda Motor Co Ltd サイドブランチ型消音装置
IT1188184B (it) * 1985-08-14 1988-01-07 Texcontor Ets Sali ammonici quaternari di polisaccaridi ad attivita' ipocolesterolemizzante
US4855139A (en) * 1987-01-20 1989-08-08 Med. Fab (Lafayette), Inc. Fungicidally active cellulosic textile compositions, or articles of manufacture
US5017565A (en) * 1989-04-20 1991-05-21 Lange Iii Louis G Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase
US5484777A (en) * 1989-04-20 1996-01-16 Lange, Iii; Louis G. Pancreatic cholesterol esterase inhibitor
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
US5419913A (en) * 1992-03-05 1995-05-30 Podell; Howard I. Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like
ZA947572B (en) * 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
US6242042B1 (en) 1998-09-14 2001-06-05 Lrc Products Ltd. Aqueous coating composition and method
EP1513358B1 (en) * 2003-09-03 2007-03-07 Research In Motion Limited Home network name displaying methods and apparatus
US20070048249A1 (en) 2005-08-24 2007-03-01 Purdue Research Foundation Hydrophilized bactericidal polymers
US8343473B2 (en) 2005-08-24 2013-01-01 Purdue Research Foundation Hydrophilized antimicrobial polymers
WO2018222622A1 (en) 2017-05-27 2018-12-06 Poly Group LLC Dispersible antimicrobial complex and coatings therefrom
EP3638740A1 (en) 2017-06-16 2020-04-22 Poly Group LLC Polymeric antimicrobial surfactant

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US26510A (en) * 1859-12-20 andrews
US3118816A (en) * 1962-04-03 1964-01-21 Abbott Lab N-succinyl heparin and process
US3320080A (en) 1964-06-05 1967-05-16 Nat Starch Chem Corp Water resistant paper coating compositions
FR2036453A5 (en) * 1969-03-14 1970-12-24 Henry Michel Cosmetic preparations additive
US3567420A (en) * 1969-04-08 1971-03-02 Shell Oil Co Use of certain polyamines as antimicrobial agents
US4080346A (en) * 1970-07-27 1978-03-21 Polaroid Corporation Novel graft copolymers having vinylbenzyl ammonium halide residues
US4144326A (en) * 1975-05-19 1979-03-13 American Cyanamid Company Oil free, water-soluble, clear creme rinse for hair
US4035146A (en) * 1975-10-20 1977-07-12 Schwarz Services International Ltd. Binding of antimicrobial compounds to a hydroxyl containing substrate with cyanuric chloride
US4131576A (en) * 1977-12-15 1978-12-26 National Starch And Chemical Corporation Process for the preparation of graft copolymers of a water soluble monomer and polysaccharide employing a two-phase reaction system
US4155885A (en) * 1978-04-28 1979-05-22 Merck & Co., Inc. Amphoteric graft copolymers of xanthomonas hydrophilic colloid and partially N-aminomethylated acrylamide
JPS6042762B2 (ja) * 1978-09-07 1985-09-25 ライオン株式会社 カチオン化多糖類を含有する化粧料
JPS6042763B2 (ja) * 1978-09-25 1985-09-25 ライオン株式会社 親和性の良好な化粧料
US4285973A (en) * 1979-07-20 1981-08-25 Alberto-Culver Company Liquid composition for application to the skin

Also Published As

Publication number Publication date
AU531118B2 (en) 1983-08-11
ES8203391A1 (es) 1982-04-01
AR227317A1 (es) 1982-10-15
JPS5952164B2 (ja) 1984-12-18
DK267681A (da) 1981-12-19
ES503199A0 (es) 1982-04-01
IT8022851A0 (it) 1980-06-18
NO812055L (no) 1981-12-21
ZA814047B (en) 1982-06-30
BE889275A (nl) 1981-10-16
AU7187381A (en) 1981-12-24
GB2078768B (en) 1983-10-05
IT1140999B (it) 1986-10-10
PH17676A (en) 1984-11-02
NL8102947A (nl) 1982-01-18
FI811832L (fi) 1981-12-19
FR2485019A1 (fr) 1981-12-24
US4459289A (en) 1984-07-10
FR2485019B1 (ja) 1984-12-07
IE811341L (en) 1981-12-18
PT73214B (en) 1982-07-16
IE51273B1 (en) 1986-11-26
PT73214A (en) 1981-07-01
DE3123806A1 (de) 1982-03-18
JPS57102903A (en) 1982-06-26
GB2078768A (en) 1982-01-13
SE8103677L (sv) 1981-12-19
GR75703B (ja) 1984-08-02

Similar Documents

Publication Publication Date Title
LU83435A1 (fr) Glucosaminoglycanes modifiees exercant une activite antilipemique et essentiellement exemptes d'activite anticoagulante
Tertov et al. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins
EP0116801B1 (fr) Héparine dépolymérisée et supersulfatée, procédé pour sa préparation et compositions pharmaceutiques en contenant
CA1175353A (fr) Procede de preparation de formes nouvelles de collagene natif ou dereticule, a structure helicoidale preservee, associees a des mucopolysaccharides et leurs applications notammentdans les domaines cosmetologiques, pharmaceutiques, analytiques et autres
EP0208623A2 (fr) Utilisation de poly- et oligosaccharides pour l'obtention de médicaments actifs dans les pathologies du tissu conjonctif
FR2474508A1 (fr) Procede pour obtenir des heparines de bas poids moleculaire ayant des proprietes pharmacologiques remarquables et produit ainsi obtenu
FR2530953A1 (fr) Emulsion perfluoro-chimique utilisable comme sang artificiel et procede pour sa preparation
FR2531857A1 (fr) Composition injectable pour prolonger la stabilite et la retention de particules enrobees, injectees dans le flux sanguin d'animaux et d'etres humains
Kita et al. Prevention of atherosclerotic progression in Watanabe rabbits by probucol
LU85639A1 (fr) Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
FR2585568A1 (fr) Compositions cosmetiques comprenant un lipide derive des cellules cornees
CA1151544A (fr) Procede de preparation de nouvelles glycoproteines extraites de klebsiella pneumoniae
Chnari et al. Nanoscale anionic macromolecules for selective retention of low-density lipoproteins
Curzon et al. Unesterified fatty acids and the binding of tryptophan in human plasma
FR2491475A1 (fr) Procede de preparation de sulfate de chondroitine et composition pharmaceutique contenant ce dernier
CA2186760C (fr) Utilisation de biopolymeres pour le traitement des muscles
TAMURA et al. Anti-thrombotic and anti-atherogenic action of eicosapentaenoic acid
Hollander et al. Changes in the connective tissue proteins, glycosaminoglycans and calcium in the arteries of the cynomolgus monkey during atherosclerotic induction and regression
PARVING et al. Acid glycosaminoglycans in myxoedema
FR2473887A1 (fr) Nouvelle utilisation des precurseurs biochimiques des glucosamino-glycanes et compositions pharmaceutiques et cosmetiques respectives
US5447720A (en) Composition and method for treatment of hemoglobinopathies
JP2884213B2 (ja) 細胞膜老化改善剤
Berenson et al. Macromolecules in the arterial wall in relation to injury and repair—A survey
JP2001187740A (ja) 創傷治療剤
SU1727080A1 (ru) Способ определени кислородной интоксикации при гипербарической терапии